Bio-Techne Corp
NASDAQ:TECH

Watchlist Manager
Bio-Techne Corp Logo
Bio-Techne Corp
NASDAQ:TECH
Watchlist
Price: 72.53 USD -0.11% Market Closed
Market Cap: $11.4B

Wall St Price Targets

TECH Price Forecast
Based on 16 analysts

+3% Upside
from $72.53 today

Bio-Techne Corp (TECH)’s 12-month stock price forecast through September 2027 has a consensus target of $74.46, implying 3% upside. The forecast is based on price targets from 16 Wall Street analysts.

TECH Analyst Rating
Based on 15 analysts

avg. 4.13 of 5
Strong buy
7 47%
Buy
3 20%
Hold
5 33%
Sell
0 0%
Strong sell
0 0%

Analysts rate TECH Buy, with 10 of 15 recommending Buy or Strong buy.

Bio-Techne Corp Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TECH's stock price target?
Price Target
74.46 USD

According to Wall Street analysts, the average 1-year price target for TECH is 74.46 USD with a low forecast of 50.5 USD and a high forecast of 82.95 USD.

What is the Revenue forecast for Bio-Techne Corp?
Projected CAGR
8%

Over the last 14 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 4 years is 8%.

What is the Gross Profit forecast for Bio-Techne Corp?
Projected CAGR
9%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 4 years is 9%.

What is the Operating Income forecast for Bio-Techne Corp?
Projected CAGR
19%

Over the last 14 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 4 years is 19%.

What is the Pre-Tax Income forecast for Bio-Techne Corp?
Projected CAGR
32%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 3 years is 32%.

What is the Net Income forecast for Bio-Techne Corp?
Projected CAGR
25%

Over the last 14 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 4 years is 25%.

Back to Top